LebrunCBensaCDebouverieMet al. Association between clinical conversion to multiple sclerosis in radiologically isolated syndrome and magnetic resonance imaging, cerebrospinal fluid, and visual evoked potential: Follow-up of 70 patients. Arch Neurol2009; 66(7): 841–846.
4.
OkudaDTSivaAKantarciOet al. Radiologically isolated syndrome: 5-year risk for an initial clinical event. PLoS ONE2014; 9(3): e90509.
5.
KantarciOHLebrunCSivaAet al. Primary progressive multiple sclerosis evolving from radiologically isolated syndrome. Ann Neurol2016; 79(2): 288–294.
6.
De StefanoNStromilloMLRossiFet al. Improving the characterization of radiologically isolated syndrome suggestive of multiple sclerosis. PLoS ONE2011; 6(4): e19452.
7.
SivaASaipSAltintasAet al. Multiple sclerosis risk in radiologically uncovered asymptomatic possible inflammatory-demyelinating disease. Mult Scler2009; 15(8): 918–927.
8.
LebrunCCohenMChaussenotAet al. A prospective study of patients with brain MRI showing incidental T2 hyperintensities addressed as multiple sclerosis: A lot of work to do before treating. Neurol Ther2014; 3: 123–132.
9.
SolomonAJBourdetteDNCrossAHet al. The contemporary spectrum of multiple sclerosis misdiagnosis: A multicenter study. Neurology2016; 87: 1393–1399.
10.
BarkhofFFilippiMMillerDHet al. Comparison of MRI criteria at first presentation to predict conversion to clinically definite multiple sclerosis. Brain1997; 120: 2059–2069.
11.
SwantonJKFernandoKDaltonCMet al. Modification of MRI criteria for multiple sclerosis in patients with clinically isolated syndromes. J Neurol Neurosurg Psy2006; 77(7): 830–833.
12.
TornatoreCPhillipsJTKhanOet al. Consensus opinion of US neurologists on practice patterns in RIS, CIS, and RRMS. Neurol Clin Pract2016; 6(4): 329–338.
13.
FernándezODelvecchioMEdanGet al. Survey of diagnostic and treatment practices for multiple sclerosis in Europe. Eur J Neurol2017; 24(3): 516–522.
14.
OkudaDLebrun FrenayCSivaAet al. Multi-center, randomized, double-blinded assessment of dimethyl fumarate in extending the time to a first attack in radiologically isolated syndrome (RIS) (ARISE Trial). Neurology2016; 84: P7.207.
15.
LebrunCSivaAKantarciOet al. Multi-center, randomized, double-blinded assessment of teriflunomide in extending the time to a first clinical event in radiologically isolated syndrome (RIS) (TERIS study). Neurology2017; 88: P6.359.